MLUNX
Price
$13.11
Change
-$0.02 (-0.15%)
Updated
Nov 13 closing price
VMVAX
Price
$88.78
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

MLUNX vs VMVAX

Header iconMLUNX vs VMVAX Comparison
Open Charts MLUNX vs VMVAXBanner chart's image
MassMutual Mid Cap Value R3
Price$13.11
Change-$0.02 (-0.15%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$88.78
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
MLUNX vs VMVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MLUNX vs. VMVAX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLUNX is a StrongBuy and VMVAX is a Buy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.9B vs. MLUNX (54.6M). VMVAX pays higher dividends than MLUNX: VMVAX (2.14) vs MLUNX (0.87). MLUNX was incepted earlier than VMVAX: MLUNX (18 years) vs VMVAX (13 years). MLUNX is a more actively managed with annual turnover of: 79.00 vs. VMVAX (22.00). MLUNX has a lower initial minimum investment than VMVAX: MLUNX (1000) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 28.30 vs. MLUNX (23.90). VMVAX return over 5 years is better than : 48.86 vs. MLUNX (7.48).
MLUNXVMVAXMLUNX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence18 years13 years-
Gain YTD14.67218.47679%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets54.6M30.9B0%
Annual Yield % from dividends0.872.1441%
Returns for 1 year23.9028.3084%
Returns for 3 years-15.1814.98-101%
Returns for 5 years7.4848.8615%
Returns for 10 years-7.60100.72-8%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
U19.13-0.09
-0.47%
Unity Software
MP19.12-0.73
-3.68%
MP Materials Corp
MLAB107.79-4.62
-4.11%
Mesa Laboratories
TTNP4.15-0.26
-6.00%
Titan Pharmaceuticals
LPTX2.99-0.25
-7.85%
Leap Therapeutics